Two cases of Clostridium difficile infection in unrelated oncology patients attributable to a single clone of C. difficile PCR ribotype 126

摘要

Clostridium difficile is a significant gastrointestinal pathogen and a leading cause of life-threatening diarrhoea in the developed world. Antibiotic therapy and immunodeficiency are key risk factors for C. difficile infection (CDI); consequently, oncology patients are at high risk.